In a new job - March 14, 2024
Cellevate appoints new Chairman of the Board of Directors
The appointment of Uwe Gottschalk follows the resignation of Mats Leifland, who served as Chairman of the Board until March 12, 2024. “Uwe Gottschalk’s appointment as new Chairman marks a major milestone for Cellevate. With his extensive industry knowledge, decades of experience, and invaluable network connections, Dr. Uwe Gottschalk is well-suited to lead Cellevate into […]
In a new job - March 13, 2024
She is KI’s Scientific Director Life Science
Professor Anna Martling has been appointed Scientific Director Life Science at Karolinska Institutet (KI). This is a new mission at KI, which involves coordinating internal initiatives and representing KI externally in the field. One of its main arenas of concern is the KI-Region Stockholm collaboration organisation. KI’s Strategy 2030 emphasises KI’s commitment to being an […]
In a new job - March 10, 2024
The new Directors of UCMR
Fredrik Almqvist and Marta Bally have been appointed as the new Directors of UCMR, the hub for microbial infection research at Umeå University. Their forward agenda includes enhancing collaboration with clinical research and establishing Biosafety Level 3 (BSL-3) labs for both in vitro and in vivo experiments, reports Umeå Biotech Incubator. Fredrik Almqvist and Marta […]
In a new job - March 5, 2024
She is the new CEO of Atlas Antibodies
The Board of Directors of Atlas Antibodies has appointed Ingela Hofverberg as the new CEO. Ingela Hofverberg joined Atlas Antibodies in August 2022 and has held several roles during her tenure, including Chief Transformation & Quality Officer and Chief Financial Officer, and has most recently served as the acting interim CEO of Atlas BU since […]
Business article - February 27, 2024
Lundbeck announces executive management changes
Jacob Tolstrup, Executive Vice President, Commercial Operations will leave Lundbeck no later than March 1, 2024. Jacob Tolstrup joined Lundbeck in 1999 and has held various management positions across the company, becoming a member of Lundbeck’s Executive Management team in 2012. “We would like to express gratitude to Jacob for his long-standing commitment to Lundbeck. Jacob has […]
In a new job - February 13, 2024
Anocca appoints Martin Welschof to its Board of Directors
Martin Welschof is currently CEO of BioInvent International. “Martin will be an important contributor as we transition to a clinical stage company and further advance our precision T-cell therapies that have the potential to transform patient outcomes in a range of hard-to-treat solid tumour indications,” says Reagan Jarvis, Co-founder, and CEO, Anocca. Martin Welschof Martin […]
